Intraocular Melanoma Terminated Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00482911Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaTreatment